Penumbra, Inc. (PEN) Stock Forecast

NYSE: PENAnalyst ratings, price target and estimates.

PEN analyst forecast

as of October 18, 2026
Analyst consensus
Hold
3.29 / 5 from 17 analysts
Price target
$362.54
average of analyst targets
Upside to target
+13.0%
from the latest close
Next earnings
November 4, 2026
EPS estimate $1.18
52-week range
$225.54 – $359.40

PEN analyst ratings

17 analysts
Strong buy
212%
Buy
16%
Hold
1482%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

PEN price target

Price $320.86Target $362.54
52-week low $225.5452-week high $359.40

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

PEN earnings per share estimates

Penumbra, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)$1.18$1.07$1.29$0.97+21.9%7
Current fiscal year (2026)$4.81$4.26$5.15$3.84+25.4%12
Next fiscal year (2027)$6.13$5.30$7.06$4.81+27.4%13

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

PEN revenue estimates

Penumbra, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$400.1M$397.6M$403.0M+12.8%7
Current fiscal year (2026)$1.59B$1.58B$1.61B+13.5%12
Next fiscal year (2027)$1.80B$1.77B$1.83B+13.0%13

PEN EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

PEN revenue: reported and forecast

Reported revenueEstimate (average; low–high)

PEN EPS estimate revisions

Penumbra, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)$1.29$1.18$1.18$1.18$1.18−8.2%1 up · 3 down
Current fiscal year (2026)$4.97$4.60$4.79$4.79$4.81−3.2%1 up · 5 down
Next fiscal year (2027)$6.27$6.13$6.13$6.13$6.13−2.3%2 up · 4 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

PEN earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; PEN beat in 10 of 12.

What analysts expect from PEN

17 analysts cover Penumbra; their consensus rating is hold (3.29 on a 1–5 scale, where 5 is a strong buy). The average price target is $362.54, 13.0% above the latest close of $320.86. Analysts expect earnings of $4.81 per share for 2026, +25.4% from a year earlier. For 2027 the average estimate is $6.13 per share on revenue of $1.8 billion. Penumbra beat the EPS estimate in 10 of the last 12 quarters.

Related: PEN income statement, PEN key metrics, PEN chart. See the PEN stock overview for the latest quote and news.

PEN forecast FAQ

What is Penumbra's price target?

The average analyst price target for Penumbra is $362.54, 13.0% above the latest close of $320.86.

Is Penumbra a buy, hold or sell?

Of 17 analysts covering Penumbra, 2 rate it a strong buy, 1 a buy, 14 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.

What is Penumbra's EPS forecast?

Analysts forecast $4.81 per share for 2026 (range $4.26 to $5.15); for 2027 the estimate is $6.13.

What is Penumbra's revenue forecast?

The average revenue estimate for 2026 is $1.6 billion, growth of 13.5%; for 2027 it is $1.8 billion.

When does Penumbra report earnings?

Penumbra is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $1.18.

Does Penumbra usually beat earnings estimates?

Penumbra reported EPS at or above the analyst estimate in 10 of the last 12 quarters.

Medical Devices: forecast